hormone therapy

Hormone therapy should not be stopped prior to mammograms

harminka — Mon, 28 Sep 2009 10:13:49 -0500

Researchers from Boston University School of Medicine (BUSM) are recommending that menopausal women on hormone therapy (HT) continue their treatment prior to having their annual mammogram screenings. These recommendations appear as an editorial in the current on-line issue of Journal of the North American Menopause Society.

Hormone therapy linked to brain shrinkage, but not lesions

harminka — Tue, 13 Jan 2009 05:56:28 -0600

Two new studies show that commonly prescribed forms of postmenopausal hormone therapy may slightly accelerate the loss of brain tissue in women 65 and older beyond what normally occurs with aging.

Hormone therapy associated with reduced colorectal cancer risk

harminka — Thu, 08 Jan 2009 03:02:54 -0600

The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.

Estrogen therapy could be dangerous for women with existing heart risk

harminka — Wed, 26 Nov 2008 02:23:03 -0600

Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests.

Hormone therapy helps short children grow up

harminka — Thu, 06 Nov 2008 08:09:26 -0600

Growth hormone treatment may significantly increase final height in children diagnosed with short stature, even in cases where the child is not growth hormone deficient, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

Large hormone dose may reduce risk of post-traumatic stress disorder

harminka — Tue, 28 Oct 2008 13:55:50 -0500

A new study by Ben-Gurion University of the Negev (BGU) researchers found that a high dose of cortisone could help reduce the risk of post-traumatic stress disorder (PTSD). The article appears in Biological Psychiatry, Volume 64, Issue 8 (October 15, 2008), pages 708-717.

High-dose hormone treatment might reduce risk for PTSD

harminka — Thu, 23 Oct 2008 10:21:10 -0500

Cortisol helps our bodies cope with stress, but what about its effects on the brain? A new study by Cohen and colleagues, appearing in the October 15th issue of Biological Psychiatry, suggests that the answer to this question is complex.

Hormone therapy before radiation seed implants for prostate cancer

harminka — Tue, 23 Sep 2008 11:53:53 -0500

Men over 70 years of age with early-stage prostate cancer have 20 percent higher mortality if they are treated first with hormone therapy before being treated with radiation seed implants (brachytherapy), compared to men who are treated with brachytherapy alone, according to the largest cohort study of its kind presented September 23, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.

When to forgo hormone therapy for prostate cancer patients

harminka — Tue, 23 Sep 2008 11:46:30 -0500

A new Fox Chase Cancer Center study suggests men with early stage prostate cancer treated with radiation therapy should begin hormone therapy immediately if their PSA level rises quickly and doubles within six months at any time after treatment.

Radiation added to hormone therapy increases survival for men with prostate cancer

harminka — Mon, 22 Sep 2008 07:38:28 -0500

For men with locally advanced prostate cancer the addition of radiation treatment to anti-androgen hormone therapy reduces the risk of dying of prostate cancer by 50 percent compared to those who have anti-androgen hormone treatment alone, according to a randomized study presented September 22, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.

Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients

harminka — Sun, 03 Aug 2008 13:21:08 -0500

Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.

Combining exercise with hormone could prevent weight gain

harminka — Wed, 28 May 2008 02:20:17 -0500

Once heralded as a promising obesity treatment, the hormone leptin lost its fat-fighting luster when scientists discovered overweight patients were resistant to its effects. But pairing leptin with just a minor amount of exercise seems to revive the hormone’s ability to fight fat again, University of Florida researchers recently discovered.